- Report
- June 2025
- 198 Pages
Global
From €2215EUR$2,500USD£1,896GBP
- Report
- May 2024
- 138 Pages
Global
From €2657EUR$2,999USD£2,274GBP
€3543EUR$3,999USD£3,033GBP
- Report
- May 2024
- 138 Pages
Global
From €2657EUR$2,999USD£2,274GBP
€3543EUR$3,999USD£3,033GBP
- Report
- February 2025
- 51 Pages
Global
From €8856EUR$9,995USD£7,580GBP
- Report
- August 2019
- 212 Pages
Global
From €13286EUR$14,995USD£11,372GBP
- Report
- December 2024
- 150 Pages
Global
From €2800EUR$3,160USD£2,397GBP
€3500EUR$3,950USD£2,996GBP
- Report
- July 2024
- 151 Pages
Global
From €3012EUR$3,400USD£2,579GBP
€3766EUR$4,250USD£3,223GBP
- Report
- July 2024
- 154 Pages
Global
From €3012EUR$3,400USD£2,579GBP
€3766EUR$4,250USD£3,223GBP
- Report
- March 2026
- 150 Pages
Germany
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
Canada
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 152 Pages
China
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
India
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- July 2024
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- January 2024
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- February 2022
- 76 Pages
Europe
From €1329EUR$1,500USD£1,138GBP
- Report
- February 2022
- 167 Pages
Global
From €3190EUR$3,600USD£2,730GBP
- Report
- March 2024
- 150 Pages
Global
From €3943EUR$4,450USD£3,375GBP

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy.
The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more